1. Home
  2. TTGT vs STRO Comparison

TTGT vs STRO Comparison

Compare TTGT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechTarget Inc.

TTGT

TechTarget Inc.

HOLD

Current Price

$5.99

Market Cap

416.4M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$37.91

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTGT
STRO
Founded
1999
2003
Country
United States
United States
Employees
N/A
131
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.4M
338.9M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
TTGT
STRO
Price
$5.99
$37.91
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$10.75
$31.33
AVG Volume (30 Days)
511.6K
252.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.45
N/A
Revenue Next Year
$2.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.41
$0.67
52 Week High
$9.00
$39.74

Technical Indicators

Market Signals
Indicator
TTGT
STRO
Relative Strength Index (RSI) 71.70 70.73
Support Level $5.44 $31.61
Resistance Level $6.43 N/A
Average True Range (ATR) 0.37 2.93
MACD 0.07 0.15
Stochastic Oscillator 87.56 79.36

Price Performance

Historical Comparison
TTGT
STRO

About TTGT TechTarget Inc.

TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: